These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32763494)

  • 21. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
    Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
    Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast.
    Wurtz N; Pascual A; Marin-Jauffre A; Bouchiba H; Benoit N; Desbordes M; Martelloni M; Pommier de Santi V; Richa G; Taudon N; Pradines B; Briolant S
    Malar J; 2012 May; 11():146. PubMed ID: 22551095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children.
    Anabwani G; Canfield CJ; Hutchinson DB
    Pediatr Infect Dis J; 1999 May; 18(5):456-61. PubMed ID: 10353520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
    Staines HM; Burrow R; Teo BH; Chis Ster I; Kremsner PG; Krishna S
    J Antimicrob Chemother; 2018 Mar; 73(3):581-595. PubMed ID: 29237012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone.
    Yeo AE; Edstein MD; Rieckmann KH
    Acta Trop; 1997 Sep; 67(3):207-14. PubMed ID: 9241385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atovaquone/proguanil for plasmodium falciparum malaria.
    Sehdev PS
    Pediatr Infect Dis J; 2002 Aug; 21(8):787-9. PubMed ID: 12192170
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasmodium falciparum malaria occurring four years after leaving an endemic area.
    Vantomme B; Van Acker J; Rogge S; Ommeslag D; Donck J; Callens S
    Acta Clin Belg; 2016 Apr; 71(2):111-3. PubMed ID: 26312505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
    Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.
    Fivelman QL; Butcher GA; Adagu IS; Warhurst DC; Pasvol G
    Malar J; 2002 Feb; 1():1. PubMed ID: 12057021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acquisition of atovaquone-proguanil resistance in imported falciparum malaria in a young child].
    Aurégan C; Argy N; Hubert V; Aprahamian A; Clain J; Cheron G
    Presse Med; 2017 Mar; 46(3):344-346. PubMed ID: 28040348
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
    Färnert A; Lindberg J; Gil P; Swedberg G; Berqvist Y; Thapar MM; Lindegårdh N; Berezcky S; Björkman A
    BMJ; 2003 Mar; 326(7390):628-9. PubMed ID: 12649236
    [No Abstract]   [Full Text] [Related]  

  • 34. A Case report of atovaquone/proguanil induced esophageal ulcers.
    Carnino L; Hulo C; Puppa G; Konan DB; Chappuis F
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 33043369
    [No Abstract]   [Full Text] [Related]  

  • 35. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
    Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
    Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
    Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H
    Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
    Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
    Llanos-Cuentas A; Campos P; Clendenes M; Canfield CJ; Hutchinson DB
    Braz J Infect Dis; 2001 Apr; 5(2):67-72. PubMed ID: 11493411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanchard A; Hine P
    Emergencias; 2023 Apr; 35(2):139-141. PubMed ID: 37038945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.